MENU

FIND DOCTORS

Name: Shao, Zhimin
Department: BREAST SURGERY
Title:Professor

 
 
Education & Professional Experience   2005-present Chairman, Breast cancer society, China Anti-cancer Association
2002-present Director, Breast Cancer Institute, Fudan University, P. R. China
2000-present Chairman, Department of Breast Surgery, Cancer Hospital/Cancer Institute, Shanghai Medical University, Shanghai, P.R.China
1998-present Professor, Department of Surgical Oncology, Molecular Biology Lab, Cancer Hospital/Cancer Institute, Shanghai Medical University, Shanghai, P.R.China 
1998-present Director, Molecular Biology Lab, Cancer Hospital/Cancer Institute, Shanghai Medical University, Shanghai, P.R.China
1996-1998 Associate Professor, Department of Surgical Oncology, Molecular Biology Lab, Cancer Hospital/Cancer Institute, Shanghai Medical University, Shanghai, P.R.China
1991-1995 Research Associate, University of Maryland Cancer Center, University of Maryland at Baltimore, MD 
1990-1991 Postdoctoral research fellow, Department of Medicine, Bowman Gray School of Medicine, Wake Forest University, NC
1987-1990 Doctor of Medicine (M.D.), Postgraduate Course on Sugical Oncology, Shanghai Medical University, Shanghai, P.R. China 
1985-1990 Residency of Surgical Oncology, Cancer Hospital, Shanghai Medical University, Shanghai, P.R. China 
1980-1985 Bachelor of Medicine, Shanghai Medical University, Shanghai, P.R. China

 
 
Specialty   Breast Surgery
 
 
Research   1986-1990
Studies on the prognostic factors in breast cancer including ER, PgR, DNA index, S phase cells and p53 in Cancer Hospital/ Cancer Institute, Shanghai, P.R. China

1990-1991
Studies on the cathepsin-D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays working wit Dr. Tim Kute in Bowman Gray School of Medicine, North Carolina

1991-1993
Studies on the insulin-like growth factor (IGF) and retinoic acid modulation of IGF-binding protein (IGFBPs) in breast cancer. Work with Dr. Joseph A. Fontana in University of Maryland Cancer Center, University of Maryland, Maryland

1993-1995
Studies on the retinoid inhibition of breast cancer Growth. Work with Dr. Joseph A. Fontana in University Of Maryland Cancer Center, University of Maryland, Maryland

1995-2000
Studies on the apoptosis and related gene expression in human breast cancer and its clinical significances.

2000-present
Mechanism of breast cancer metastasis.
 
 
Publication   1.Fan L, Zheng Y, Yu KD, Liu GY, Wu J, Lu JS, Shen KW, Shen ZZ, Shao ZM. Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat. 2009;117(2):409-16 【IF 5.7】
2.Li XF, Yan PJ, Shao ZM. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Oncogene. 2009;28(44):3937-48 【IF 7.2】
3.Feng LY, Ou ZL, Wu FY, Shen ZZ, Shao ZM. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin Cancer Res. 2009;15(9):2962-70 【IF 6.4】
4.Yu KD, Di GH, Yuan WT, Fan L, Wu J, Hu Z, Shen ZZ, Zheng Y, Huang W, Shao ZM. Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53. Hum Mol Genet. 2009;18(13):2502-17 【IF 7.2】
5.Yu KD, Di GH, Fan L, Wu J, Hu Z, Shen ZZ, Huang W, Shao ZM. A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer. FASEB J. 2009;23(7):2274-87 【IF 7.0】
6.Yin W, Di G, Zhou L, Lu J, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z. Time-varying pattern of recurrence risk for Chinese breast cancer patients. Breast Cancer Res Treat. 2009;114(3):527-35 【IF 5.7】
7.Rao NY, Hu Z, Li WF, Huang J, Ma ZL, Zhang B, Su FX, Zhou J, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Yuan WT, Shen ZZ, Huang W, Shao ZM. Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients. Breast Cancer Res Treat. 2009;113(3):467-77 【IF 5.7】
8.Li LF, Xu XJ, Zhao Y, Liu ZB, Shen ZZ, Jin WR, Shao ZM. Integrated gene expression profile predicts prognosis of breast cancer patients. Breast Cancer Res Treat. 2009;113(2):231-7 【IF 5.7】
9.Li WF, Hu Z, Rao NY, Song CG, Zhang B, Cao MZ, Su FX, Wang YS, He PQ, Di GH, Shen KW, Wu J, Lu JS, Luo JM, Liu XY, Zhou J, Wang L, Zhao L, Liu YB, Yuan WT, Yang L, Shen ZZ, Huang W, Shao ZM. The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat. 2008, 110(1):99-109. 【IF 5.7】
10.Huang O, Wang L, Shen K, Lin H, Hu Z, Liu G, Wu J, Lu J, Shao Z, Han Q, Shen Z. Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2,269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat. 2008, 107(3):379-87 【IF 5.7】
 
 
Awards   Distinguished professor of Chang Jiang Scholars Program, 1999
2nd National Prize for Progress in Science and Technology, 2004
National Excellent Youth Foundation, 2000
National 5.1 Labor Medal, 2008 Life Science Award, Shanghai, MEIJI Dairies Corp, 1998
Guanghua Youth Prize of Chinese Academy of Engineering, 2006
1st Prize for Progress in Science and Technology, National Ministry of Education, 2008
1st Prize for Progress in Science and Technology, National Ministry of Health, 1997
2nd Prize for Progress in Science and Technology, Shanghai, 1997;2001;2002;2003;2009
3rd Prize for Progress in Science and Technology, Shanghai, 1998;1999;2006
 
 
Out-patient Schedule  

Monday morning, Wednesday morning